Clinical Trial Update: Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial update of haploidentical transplantation with donor natural killer cells for solid tumors; the study was terminated and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumors
• Ewing Sarcoma
• Neuroblastoma
• Osteosarcoma
• Rhabdomyosarcoma

Drugs mentioned

• Donor-derived natural killer cell therapy (natural killer cells)
• Haploidentical hematopoietic stem cell transplantation (haploidentical hematopoietic stem cell transplantation)

Snippet

Sponsor: Monica Thakar | Conditions: Ewing Sarcoma, Neuroblastoma | Phase 2 | Status: TERMINATED | Results posted: 2025-03-19